Acute kidney injury is an early predictor of mortality for patients with alcoholic hepatitis

Clinical Gastroenterology and Hepatology

Volumn 10, Issue 1, 2012, Pages

  Altamirano, José ^a,b   Fagundes, Claudia ^a,c   Dominguez, Marlene ^a   García, Elisabet ^a,c   Michelena, Javier ^a,b   Cárdenas, Andrés ^a   Guevara, Monica ^a   Pereira, Gustavo ^a,c   Torres Vigil, Karina ^a,b   Arroyo, Vicente ^a,b   Caballería, Juan ^a,c   Ginès, Pere ^a,c   Bataller, Ramón ^a,b,c  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Nanomalaria Group   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Acute Kidney Injury; Alcoholic Hepatitis; Alcoholic Liver Disease; Liver Disease; Prognosis

Indexed keywords

BILIRUBIN; CORTICOSTEROID; CREATININE;

ACUTE KIDNEY FAILURE; ACUTE KIDNEY INJURY NETWORK CRITERIA; ADULT; ALCOHOL LIVER DISEASE; ARTICLE; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CREATININE BLOOD LEVEL; FEMALE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HUMAN TISSUE; INTERNATIONAL NORMALIZED RATIO; KIDNEY FAILURE; KIDNEY FUNCTION; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; MORTALITY; RETROSPECTIVE STUDY; SCORING SYSTEM; SURVIVAL RATE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 83855165691     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2011.09.011     Document Type: Article

References (32)

1. Parés A., Caballería J., Bruguera M., et al. Histological course of alcoholic hepatitis. Influence of abstinence, sex and extent of hepatic damage. J Hepatol 1986, 2:33-42.
2. Dominguez M., Miquel R., Colmenero J., et al. Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis. Gastroenterology 2009, 136:1639-1650.
3. Louvet A., Diaz E., Dharancy S., et al. Early switch to pentoxifylline in patients with severe alcoholic hepatitis is inefficient in non-responders to corticosteroids. J Hepatol 2008, 48:465-470.
4. Dominguez M., Rincón D., Abraldes J.G., et al. A new scoring system for prognostic stratification of patients with alcoholic hepatitis. Am J Gastroenterol 2008, 103:2747-2756.
5. Palevsky P.M. Epidemiology of acute renal failure: the tip of the iceberg. Clin J Am Soc Nephrol 2006, 1:6-7.
6. Mehta R.L., Kellum J.A., Shah S.V., et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007, 11:R31.
7. Ricci Z., Cruz D., Ronco C. The RIFLE criteria and mortality in acute kidney injury: a systematic review. Kidney Int 2008, 73:538-546.
8. Leithead J.A., Ferguson J.W., Bates C.M., et al. The systemic inflammatory response syndrome is predictive of renal dysfunction in patients with non-paracetamol-induced acute liver failure. Gut 2009, 58:443-449.
9. Garcia-Tsao G., Sanyal A.J., Grace N.D., et al. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology 2007, 46:922-938.
10. Moore K.P., Wong F., Gines P., et al. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology 2003, 38:258-266.
11. Runyon B.A. Practice Guidelines Committee, American Association for the Study of Liver Diseases (AASLD), management of adult patients with ascites due to cirrhosis. Hepatology 2004, 39:841-855.
12. Ferenci P., Lockwood A., Mullen K., et al. Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002, 35:716-721.
13. Bosch J., Abraldes J.G., Berzigotti A., et al. The clinical use of HVPG measurements in chronic liver disease. Nat Rev Gastroenterol Hepatol 2009, 6:573-582.
14. Bone R.C., Balk R.A., Cerra F.B., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101:1644-1655.
15. D'Amico G., Garcia-Tsao G., Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006, 44:217-231.
16. Cholongitas E., Calvaruso V., Senzolo M., et al. RIFLE classification as predictive factor of mortality in patients with cirrhosis admitted to intensive care unit. J Gastroenterol Hepatol 2009, 24:1639-1647.
17. Louvet A., Naveau S., Abdelnour M., et al. The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids. Hepatology 2007, 45:1348-1354.
18. Fujimoto M., Uemura M., Nakatani Y., et al. Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance. Alcohol Clin Exp Res 2000, 24(Suppl 4):48S-54S.
19. Rangel-Frausto M.S., Pittet D., Costigan M., et al. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 1995, 11:117-123.
20. Cazzaniga M., Dionigi E., Gobbo G., et al. The systemic inflammatory response syndrome in cirrhotic patients: relationship with their in-hospital outcome. J Hepatol 2009, 51:475-482.
21. Louvet A., Wartel F., Castel H., et al. Infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor. Gastroenterology 2009, 137:541-548.
22. Katoonizadeh A., Laleman W., Verslype C., et al. Early features of acute-on-chronic alcoholic liver failure: a prospective cohort study. Gut 2010, 59:1561-1569.
23. Wasmuth H.E., Kunz D., Yagmur E., et al. Patients with acute on chronic liver failure display "sepsis-like" immune paralysis. J Hepatol 2005, 42:195-201.
24. Mehta R.L., Bouchard J., Soroko S.B., et al. Sepsis as a cause and consequence of acute kidney injury: program to improve care in acute renal disease. Intensive Care Med 2011, 37:241-248.
25. Terra C., Guevara M., Torre A., et al. Renal failure in patients with cirrhosis and sepsis unrelated to spontaneous bacterial peritonitis: value of MELD score. Gastroenterology 2005, 129:1944-1953.
26. Simmons E.M., Himmelfarb J., Sezer M.T., et al. Plasma cytokine levels predict mortality in patients with acute renal failure. Kidney Int 2004, 65:1357-1365.
27. Thabut D., Massard J., Gangloff A., et al. Model for end-stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure. Hepatology 2007, 46:1872-1882.
28. Cárdenas A., Ginès P., Uriz J., et al. Renal failure after upper gastrointestinal bleeding in cirrhosis: incidence, clinical course, predictive factors, and short-term prognosis. Hepatology 2001, 34:671-676.
29. Fasolato S., Angeli P., Dallagnese L., et al. Renal failure and bacterial infections in patients with cirrhosis: epidemiology and clinical features. Hepatology 2007, 45:223-229.
30. Sort P., Navasa M., Arroyo V., et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999, 341:403-409.
31. Baldus W.P., Feichter R.N., Summerskill W.H. The kidney in cirrhosis. I. Clinical and biochemical features of azotemia in hepatic failure. Ann Intern Med 1964, 60:353-365.
32. Lopes J.A., Fernandes P., Jorge S., et al. Acute kidney injury in intensive care unit patients: a comparison between the RIFLE and the Acute Kidney Injury Network classifications. Crit Care 2008, 12:R110.